Trials / Completed
CompletedNCT02286778
Eradication of Malignant Carcinoma in the Breast Tissue
The Eradication of Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Optimal Health Research · Academic / Other
- Sex
- Female
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Acetogenins | Acetogenins BID for 12 months |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-01-01
- Completion
- 2017-08-01
- First posted
- 2014-11-10
- Last updated
- 2017-08-03
Source: ClinicalTrials.gov record NCT02286778. Inclusion in this directory is not an endorsement.